I am writing to you regarding a paper entitled ‘Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals’, which was ...
Despite pharmacologic advances in the treatment of heart failure (HF), mortality and morbidity remain unacceptably high. Moreover, for patients with end-stage HF therapeutic options are limited to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results